For the average person, the time before the start of the holiday season is the low point in an annual weight gain pattern that peaks during the holidays and takes nearly half a year to fully shed.
Research involving cancer-targeting silica particles, known as Cornell dots, has shown that the particles can neutralize nutrient-deprived cancer cells by a cell-death process called ferroptosis.
Cornell’s New York State Agricultural Experiment Station in Geneva is poised to expand its food development and technology commercialization capabilities with $1 million in new state funding.
An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.
New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.
Weill Cornell Medicine and Cornell's Samuel Curtis Johnson Graduate School of Management today announced a new dual MBA/M.S. degree program for health care leaders.
MRI-guided ultrasound ablation, a new noninvasive treatment for tremors being offered at Weill Cornell Medicine, is helping people with essential tremors.
Researchers from the College of Engineering and Weill Cornell Medicine will fight the spread of breast cancer and other cancers with a $9.3M, five-year grant from the National Cancer Institute.
